Ruyi Zhang
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels.
Journal: Oncogene
Published: July 08, 2024
Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 12, 2023
Issues with RNF43 antibodies to reliably detect intracellular location.
Journal: PloS one
Published: November 02, 2022
Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids.
Journal: Science advances
Published: January 19, 2022
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling.
Journal: Antiviral research
Published: September 25, 2021
Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: July 12, 2021
The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Journal: International journal of antimicrobial agents
Published: January 19, 2021
Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Journal: Antiviral research
Published: August 07, 2020
The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 04, 2020
Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Journal: Scientific reports
Published: April 28, 2020
Last Updated: 09/26/2026